BioSpace News Archive

Storage chambers, warehouses, manufacturing facilities and laboratories are just a few environments where precise temperature and humidity control is an essential component of the operation, particularly in regulated life science fields.

Biobeat, a bio-medical technology company developing advanced sensing and remote monitoring solutions for patients, announced today that the U.S. Food and Drug Administration (FDA) has granted a 510K clearance for its patch and watch for measurement of blood pressure, oxygenation and heart rate in hospitals, clinics, long-term care and at home

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this Summer to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research. [26-August-2019] EL PASO, Texas , Aug. 26, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501c3 non-profit organization supported by Hyundai and its U.S. dealers, announces $100,000

The global corneal pachymetry market size is poised to grow by USD 649.92 million during 2019-2023, according to a new report by Technavio, progressing at a CAGR of close to 5% during the forecast period.

According to Coherent Market Insights, the U.S. sucralfate market was valued at US$ 296.2 million in 2017, and is projected to exhibit a CAGR of 3.1% over the forecast period.

Chartspan, the largest Chronic Care Management provider in the United States, has announced that Sarath Degala, Senior Vice President of BIP Capital, has been appointed to its new Board of Directors

Impaired driving is a leading cause of criminal death and injury in Canada. Far too many Canadians are risking their lives and the lives of others driving while impaired by cannabis or other drugs.

Nearly 5,000 people in the US and 3,500 people in Europe die each year while waiting for a kidney transplant. Yet in the US, over 3,500 donated kidneys are discarded annually.

FEI Systems, a Columbia, Maryland-based provider of health IT solutions celebrates its 20th anniversary this year.

The Australian Government invests $40 million to provide patients affordable access to two new medicine listings through the Pharmaceutical Benefit Scheme (PBS)